Embrace Artificial Intelligence in the Pharmacy
Drug Topics
OCTOBER 4, 2022
As technology advances in all areas of life, it is no surprise that technology is becoming more prevalent in independent pharmacy.
Drug Topics
OCTOBER 4, 2022
As technology advances in all areas of life, it is no surprise that technology is becoming more prevalent in independent pharmacy.
IDStewardship
OCTOBER 27, 2022
In this article an infectious diseases pharmacist discusses antibiotic myths. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 27 October 2022. Have you ever seen the show MythBusters on the Discovery Channel? Well this blog post is not nearly as cool as that show, but it may be a fun read at least! Here are 15 antibiotic myths to beware… Myth 1: Stopping antibiotic courses early leads to antibiotic resistance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
OCTOBER 5, 2022
America relies on the U.S. Food & Drug Administration (FDA) to keep pace with the scientific advancements happening every day in labs across the country. That’s why the recently enacted Prescription Drug User Fee Act (PDUFA VII) and Biosimilar User Fee Act (BsUFA III) are both great news for biopharmaceutical innovation and for patients. With these programs reauthorized for another five years, the FDA can continue doing its vital work reviewing medicines.
PharmaVoice
OCTOBER 19, 2022
Major recent trial flops and what they mean for companies, patients and the industry.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
OCTOBER 14, 2022
A presentation at the AMCP Nexus conference focuses on the health care disparities and pharmacotherapy options for gender affirmation.
STAT
OCTOBER 17, 2022
Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus is garnering heated headlines alleging the scientists involved could have unleashed a new pathogen. There is no evidence the work, performed under biosecurity level 3 precautions in BU’s National Emerging Infectious Diseases Laboratories, was conducted improperly or unsafely.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
IDStewardship
OCTOBER 10, 2022
In this article a pharmacist with specialized training in infectious diseases discusses five key areas of study to master in the field of antimicrobial pharmacotherapy, to become an antibiotic ninja. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 11 October 2022. It is commonplace for learners such as students and residents to struggle with infectious diseases pharmacotherapy.
PhRMA
OCTOBER 4, 2022
Each first week of October, Americans all across the country take time to reflect on an issue which is increasingly recognized as impacting everyone, whether it be directly as it does me, or indirectly through a family member or friend: mental illness. Mental Illness Awareness Week is an opportunity to raise awareness about the impacts of mental illness and to better understand and educate communities about what it means to face a mental illness, deal with significant moments of stress throughou
PharmaVoice
OCTOBER 31, 2022
How new tools are helping companies find and keep cancer patients in clinical studies.
Pharmacy Times
OCTOBER 31, 2022
Purpose-built assisted reality solutions help streamline processes and maintain regulatory compliance from the laboratory to the factory floor.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Store News
OCTOBER 19, 2022
The scholarships represent a commitment to an inclusive community and promoting diversity of thought, background, perspective and experience to advance pharmacy education and improve patient health.
Drug Topics
OCTOBER 10, 2022
Readers, we want to hear from you.
IDStewardship
OCTOBER 28, 2022
In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Authored by: Hunter O. Rondeau, Pharm.D. Article Posted 28 October 2022. Virtual recruitment for post-graduate residency programs continues to find its place, especially now with the upcoming in-person Midyear after two years of an “online-only” environment.
PhRMA
OCTOBER 26, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
OCTOBER 10, 2022
Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.
Pharmacy Times
OCTOBER 18, 2022
A new review identified vitamin D as an important factor in maintaining endothelial progenitor cell health and function, which can impact risk of developing cardiovascular disease.
STAT
OCTOBER 12, 2022
After pushing for several hours, my patient looks exhausted but happy, clutching her seconds-old newborn to her chest. As I help her put her baby to breast for the first time, she isn’t thinking about anything other than the tiny human blinking up at her. As well she shouldn’t.
Drug Topics
OCTOBER 13, 2022
From biosimilars to artificial intelligence, these are the trends poised to take community pharmacy by storm.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
OCTOBER 6, 2022
An artificial intelligence-powered digital health worker has been unveiled by the World Health Organisation (WHO) as its latest tool for disseminating reliable health information to the public. Originally developed by New Zealand tech company Soul Machines with support of the Qatar Ministry of Health, the first version of the virtual health worker was used to combat misinformation about the pandemic.
PhRMA
OCTOBER 5, 2022
Insurer-imposed barriers like high deductibles and coinsurance shift the cost of life-saving care onto patients. Manufacturers and others have stepped forward to assist patients who face high out-of-pocket costs, using programs like copay coupons to help eligible, commercially insured patients afford their out-of-pocket costs. In fact, the share of patients staying on treatment for one year increased by up to 47% when patients used copay coupons.
PharmaVoice
OCTOBER 21, 2022
C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.
Pharmacy Times
OCTOBER 17, 2022
A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.
STAT
OCTOBER 4, 2022
A little over a century ago, scientists working in laboratories discovered that microbes were the cause of many epidemics. Once they understood that, they began to put their faith more and more in laboratory science. This major transformation, called the bacteriological revolution, began in the 1880s. During this period, diphtheria was one of the leading causes of death among mostly poor children in New York City.
Drug Topics
OCTOBER 4, 2022
Does the severe flu season in the southern hemisphere hint at a tough season for the north?
The Guardian - Pharmaceutical Industry
OCTOBER 16, 2022
Health secretary accused of ‘monumental stupidity’ for saying she had shared a prescribed medication Doctors have rounded on the health secretary, Thérèse Coffey, after she admitted to sharing prescription medicines with others, actions the British Medical Association described as both dangerous and against the law. Coffey told civil servants in a meeting last month that she had given leftover antibiotics to a poorly friend, an admission that came as the discussion on how to alleviate pressures
PhRMA
OCTOBER 6, 2022
The 340B Drug Pricing Program was designed to help vulnerable patients improve access to their medicines through manufacturer discounts to specific safety-net, non-profit hospitals and federally funded clinics. The biopharmaceutical industry has long supported this program, but unfortunately, 340B has strayed far from its purpose, with more and more for-profit health care entities using these discounts for themselves.
PharmaVoice
OCTOBER 18, 2022
Drug developers have been making headway in treating the most difficult and deadly forms of breast cancer.
Pharmacy Times
OCTOBER 17, 2022
Pharmaceutical companies are looking into AI as the new method to not only reduce research and development costs, but also prevent costly errors.
STAT
OCTOBER 12, 2022
The scientist flicked on a laser, filling the rat’s brain with blue light. The rodent, true to its past two weeks of training, scampered across its glass box to a tiny spout, where it was duly rewarded with a drink of water. From the outside, this would appear to be a pretty run-of-the-mill neuroscience experiment, except for the fact that the neurons directing the rat to its thirst-quenching reward didn’t contain any rat DNA.
Drug Topics
OCTOBER 4, 2022
Changes to DIR fees are coming. Taking proactive steps can help pharmacies avoid feeling the pinch.
European Pharmaceutical Review
OCTOBER 9, 2022
Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases. Natural sources of the compound can only be found in a small section of the Northeastern Australia rainforest, in fruit seeds from the blushwood tree ( Fontainea picrosperma ).
PharmaVoice
OCTOBER 26, 2022
The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.
Let's personalize your content